The PDX ROS1-fusion tumor cell line, LUAD-0006, is resistant to
PDF) NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis
Sudarshan Iyer's research works
Inna Khodos's research works Memorial Sloan Kettering Cancer
Inna Khodos's research works Memorial Sloan Kettering Cancer
Igor Odintsov's research works Brigham and Women's Hospital
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles, Journal of Translational Medicine
Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development. - Abstract - Europe PMC
Igor Odintsov's research works Brigham and Women's Hospital
PDF) Pre-clinical modelling of ROS1+ non-small cell lung cancer